May 17, 2018
Aptinyx Appoints Robert Hombach to Board of Directors
May 15, 2018
Shire Recognizes MPS Awareness Day 2018 with Digital Campaign and Global Events Focused on Increasing Diseases Awareness
Apr 20, 2018
Saga Nagoya Securities Comments on Allergan and Shire Pharmaceutical Acquisition
Mar 29, 2018
Behavioral Disorders Drug Development Pipeline Review 2017 - Key Players Involved in Therapeutic Development for Autism, OCD and ADHD
Feb 08, 2018
Global Investors Back Rani Therapeutics With $53 Million As Company Moves To Clinical Trials
Feb 01, 2018
Orphan Drugs Market Report 2018-2028
Jan 03, 2018
Xiidra®* (Lifitegrast Ophthalmic Solution 5%) Approved by Health Canada To Treat the Signs and Symptoms of Dry Eye Disease
Dec 18, 2017
50 Key Biotech Companies Shaping the Biotherapeutics Market: Report
Oct 27, 2017
Technical Snapshots for These Drug Makers Stocks -- Immune Pharma, Zogenix, Shire, and AbbVie
Oct 03, 2017
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
Sep 11, 2017
Daily Technical Summary Reports on Healthcare Stocks -- Shire, Aerie Pharma, Heron Therapeutics, and United Therapeutics
Aug 08, 2017
Rare Disease Treatment Market to Reach US$ 198,487 Mn by 2025, Globally - PMR's Study
Jul 26, 2017
The Galien Foundation Debuts 2017 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories
Jul 26, 2017
Drug Makers Stock Performance Review -- Alliqua BioMedical, Aerie Pharma, Shire, and Heron Therapeutics
Jul 24, 2017
Global Genes Announces RARE Champion of Hope Award Recipients to be Honored at 6th Annual RARE Tribute and Patient Advocacy Summit
Jun 22, 2017
Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease